US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims

Investing.com Gold reports: US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims. Full body text was unavailable at ingest time, so this brief is based on headline context.